1089178-91-5

Upstream product

• 1089178-89-1 C₁₆H₂₃NO₃Si 
• 1089178-87-9 C₁₄H₁₉NO₂Si 
• 1089178-86-8 C₁₃H₁₈BrNOSi 
• 156682-52-9 1,4-dibromo-2,3-difluoro-benzene 
• 1089178-88-0 C₁₀H₉NO₃ 

Downstream Products

• 1089178-92-6 C₁₇H₁₁BrFNO₄ 
• 1089178-94-8 C₁₅H₉BrFNO₃ 
• 1089178-97-1 C₁₅H₇Br₂FN₂O 
• 1089178-96-0 C₁₅H₈BrFN₂O₂ 
• 1095279-47-2 C₁₅H₉BrF₃NO₂ 
• 1089179-05-4 C₁₇H₁₁BrFNO₄ 
• 1089178-95-9 C₁₅H₁₀BrFN₂O₃ 
• 1095279-44-9 C₁₇H₁₁BrF₃NO₃ 
• 1089178-93-7 C₁₇H₁₃BrFNO₄ 
• 1089179-04-3 C₁₉H₁₅BrFNO₅ 

Relevant academic research and scientific papers

Non-Nucleoside reverse transcriptase inhibitors

Compounds of formula I, wherein R1, R2, R3, X and Ar, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula I useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

Compounds of formula (I), wherein R1, X1, X2 and A, are as defined herein or pharmaceutically acceptable salts thereof, inhibit HIV-1 reverse transcriptase and afford a method for prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC. The present invention also relates to compositions containing compounds of formula (I) useful for the prevention and treatment of HIV-1 infections and the treatment of AIDS and/or ARC.